Restoration of caveolin-1 expression suppresses growth, membrane-type-4 metalloproteinase expression and metastasis-associated activities in colon cancer cells

Molecular Carcinogenesis

Volumn 52, Issue 11, 2013, Pages 859-870

  Nimri, Lili ^a   Barak, Hossei ^b   Graeve, Lutz ^b   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Caveolin 1; Colon cancer; Flotillin 1; Lipid rafts; MT MMP

Indexed keywords

CAVEOLIN 1; FLOTILLIN 1; MATRIX METALLOPROTEINASE 17; FLOTILLINS; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL INVASION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; LIPID RAFT; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL MEMBRANE; CELL PROLIFERATION; COLON; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROTEOMICS; TUMOR CELL LINE; UPREGULATION;

MAMMALIA; MUS; MUS MUSCULUS;

ANIMALS; CAVEOLIN 1; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 17; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROTEOMICS; UP-REGULATION;

EID: 84886314631     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21927     Document Type: Article

References (36)

1. Goetz JG, Lajoie P, Wiseman SM, Nabi IR. Caveolin-1 in tumor progression: The good, the bad and the ugly. Cancer Metastasis Rev 2008; 27:715-735.
2. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288:C494-C506.
3. Cerezo A, Guadamillas MC, Goetz JG, et al. The absence of caveolin-1 increases proliferation and anchorage-independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol 2009; 29:5046-5059.
4. Lajoie P, Nabi IR. Regulation of raft-dependent endocytosis. J Cell Mol Med 2007; 11:644-653.
5. Williams TM, Lisanti MP. The Caveolin genes: From cell biology to medicine. Ann Med 2004; 36:584-595.
6. Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, Fridman R. MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: Properties and expression in cancer. Cancer Metastasis Rev 2008; 27:289-302.
7. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010; 141:52-67.
8. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25:9-34.
9. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69:562-573.
10. Kim HN, Chung HS. Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity. BMB Rep 2008; 41:858-862.
11. Prat A, Casado E, Cortes J. New approaches in angiogenic targeting for colorectal cancer. World J Gastroenterol 2007; 13:5857-5866.
12. Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 2000; 60:5870-5878.
13. Rikimaru A, Komori K, Sakamoto T, et al. Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using beta-galactosidase. Genes Cells 2007; 12:1091-1100.
14. Nuttall RK, Pennington CJ, Taplin J, et al. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 2003; 1:333-345.
15. Riddick AC, Shukla CJ, Pennington CJ, et al. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 2005; 92:2171-2180.
16. Chabottaux V, Sounni NE, Pennington CJ, et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res 2006; 66:5165-5172.
17. Barshishat M, Ariel A, Cahalon L, Chowers Y, Lider O, Schwartz B. TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells. Clin Exp Metastasis 2002; 19:327-337.
18. Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 2004; 23:7893-7897.
19. Zhang H, Su L, Muller S, et al. Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 2008; 99:1684-1694.
20. Forsyth NR, Morales CP, Damle S, et al. Spontaneous immortalization of clinically normal colon-derived fibroblasts from a familial adenomatous polyposis patient. Neoplasia 2004; 6:258-265.
21. Roy UK, Henkhaus RS, Ignatenko NA, Mora J, Fultz KE, Gerner EW. Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc. Mol Carcinog 2008; 47:947-955.
22. Banyard J, Anand-Apte B, Symons M, Zetter BR. Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 2000; 19:580-591.
23. Nobes CD. Rho GTPases and cell migration-fibroblast wound healing. Methods Enzymol 2000; 325:441-449.
24. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005; 33:891-895.
25. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 2005; 4:21.
26. Jaffe T, Schwartz B. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 2008; 123:2543-2556.
27. Vassilieva EV, Ivanov AI, Nusrat A. Flotillin-1 stabilizes caveolin-1 in intestinal epithelial cells. Biochem Biophys Res Commun 2009; 379:460-465.
28. Rizki A, Weaver VM, Lee SY, et al. A human breast cell model of preinvasive to invasive transition. Cancer Res 2008; 68:1378-1387.
29. Huang CH, Yang WH, Chang SY, et al. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 2009; 11:1371-1382.
30. Kuan SF, Byrd JC, Basbaum CB, Kim YS. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res 1987; 47:5715-5724.
31. Bresalier RS, Schwartz B, Kim YS, Duh QY, Kleinman HK, Sullam PM. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res 1995; 55:2476-2480.
32. Schwartz B, Bresalier RS, Kim YS. The role of mucin in colon-cancer metastasis. Int J Cancer 1992; 52:60-65.
33. Osterhues A, Liebmann S, Schmid M, et al. Stem cells and experimental leukemia can be distinguished by lipid raft protein composition. Stem Cells Dev 2006; 15:677-686.
34. Lavi I, Levinson D, Peri I, Tekoah Y, Hadar Y, Schwartz B. Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from Pleurotus pulmonarius mycelium and fruiting bodies. Appl Microbiol Biotechnol 2010; 85:1977-1990.
35. Schwartz B, Shoseyov O, Melnikova VO, et al. ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Res 2007; 67:5258-5266.
36. Olsen JV, de Godoy LM, Li G, et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005; 4:2010-2021.